Container Closure Integrity (CCI) is a fundamental requirement for the pharmaceutical industry

Oct 08, 2024

Analytical Services

Posted by Stevanato Group

Ensuring that the Critical Quality Attributes of your drug product are maintained throughout the product lifecycle in primary containers is crucial.
This is why Container Closure Integrity (CCI) is a fundamental requirement for the pharmaceutical industry.

Our experts explains the role of CCI Testing and how our Technology Excellence Centers can help you decide on the appropriate tests to identify the optimal primary packaging, reduce complexity, as well as help you meet the latest regulatory requirements.

Watch our latest interview to discover how our Technology Excellence Centers can help you make newer, better, and safer medications:  https://lnkd.in/dw6va3RK 

Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

See all Member News